Drug Discovery World

JUNE 7, 2023

That’s why at Macomics we have developed the ENIGMAC discovery platform, which allows stringent bioinformatic analysis coupled with macrophage gene editing technology; our platform enables strong target validation and drug screening using biologically relevant functional assays.

In-Vivo 52

In-Vivo Gene Editing Engineer Bioinformatics 52

Drug Discovery World

APRIL 14, 2023

He is being recognised for his revolutionary contributions to developing the first gene-edited cell-based therapy for cancer that involves the genetic re-engineering of a patient’s own T cells to combat their disease, and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer.

Genetics 52

Genetics Research Medicine Clinical Research 52

Drug Discovery World

FEBRUARY 21, 2023

Breakthroughs in synthetic biology Pillai explains that in recent years, there have been significant improvements to the gene editing space within the synthetic biology sector. He says: “Organisms can be edited and synthesised to test out different mutations for improvement in function.

Scientist 52

Scientist Gene Editing Engineer Bioinformatics 52

Drug Discovery World

NOVEMBER 30, 2023

In addition, the company presented three posters: ‘Integration of next-generation transposon vectors with state-of-art host cell lines’, ‘Application of gene editing technologies to improve biotherapeutic manufacturing’, and ‘CHOSOURCE ADCC+ cell line for enhanced therapeutic potency’.

Antibody 59

Antibody Protein Engineer In-Vivo 59